C12Q 2522/10
Nucleic acid binding proteins
C12Q2522/10 (Nucleic acid binding proteins) appears on 59 US grants and 96 published applications in this corpus.
Search patents in C12Q- Granted patents
- 59
- Published applications
- 96
- Assignees
- 52
- Inventors
- 121
- Latest grant
- 1 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2003 | 0 | 1 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 1 |
| 2008 | 1 | 0 |
| 2009 | 0 | 0 |
| 2010 | 1 | 1 |
| 2011 | 0 | 1 |
| 2012 | 0 | 1 |
| 2013 | 0 | 1 |
| 2014 | 1 | 3 |
| 2015 | 1 | 3 |
| 2016 | 3 | 1 |
| 2017 | 3 | 12 |
| 2018 | 4 | 17 |
| 2019 | 8 | 12 |
| 2020 | 10 | 11 |
| 2021 | 6 | 6 |
| 2022 | 2 | 7 |
| 2023 | 5 | 3 |
| 2024 | 5 | 7 |
| 2025 | 5 | 7 |
| 2026 | 4 | 1 |
By publication year. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Methods for genome assembly and haplotype phasing1 Sep 2026US 12,725,678 B2The Regents of the University of California
- RNA-directed DNA cleavage by the Cas9-crRNA complex23 Jun 2026US 12,662,668 B2Vilnius University
- Method for designing RNA binding protein utilizing PPR motif, and use thereof2 Jun 2026US 12,646,586 B2Kyushu University, National University Corporation
- Isolated nucleic acid binding domains28 Apr 2026US 12,612,615 B2
- Selective oxidation of 5-methylcytosine by tet-family proteins11 Nov 2025US 12,467,082 B2Children's Medical Center Corporation
- Method for designing rna binding protein utilizing ppr motif, and use thereof14 May 2026US 2026/0134942 A9Kyushu University, National University Corporation
- Methods of Epigenetic Analysis20 Nov 2025US 2025/0354202 A1Children's Medical Center Corporation
- Selective oxidation of 5-methylcytosine by tet-family proteins20 Nov 2025US 2025/0354203 A1The Children Medical Center Corporation
- Methods and compositions for enriching nucleic acids11 Sep 2025US 2025/0283148 A1Asklepios Biopharmaceutical, Inc.
- Selective oxidation of 5-methylcytosine by tet-family proteins29 May 2025US 2025/0171831 A1Children's Medical Center Corporation
Most cited
By later US patents
- In vitro recombination method73US 7,723,077 B2Synthetic Genomics, Inc. · 2010
- Assay methods using nicking endonucleases69US 8,715,933 B2NABsys, Inc. · 2014
- In vitro recombination method49US 9,534,251 B2Synthetic Genomics, Inc. · 2017
- Selective oxidation of 5-methylcytosine by TET-family proteins46US 9,447,452 B2Children's Medical Center Corporation · 2016
- Selective oxidation of 5-methylcytosine by TET-family proteins41US 9,115,386 B2Children's Medical Center Corporation · 2015